Topics:

Sleep Disorders

Additions to Our Sleep Armamentarium

The latest developments in pharmacokinetic and pharmacodynamic approaches to treating sleep disorders.

Sleep Disorders

©foxterrier2005-shutterstock

Circadian components are profound in depressive disorders, such seasonal affective disorder. This article introduces a course to be given at this year’s APA Meeting in Toronto, on melatonin and light treatment.

The human condition is such that all of us may be vulnerable to seasonal affective disorder. If placed in an environment sufficiently deprived of light we would all develop a reversible syndrome of major depression.

Good physical and social functioning may help avert insomnia in older people with musculoskeletal pain.

Orexin B protects vulnerable midbrain neurons from degeneration and preserves their function. This sleep-promoting protein could provide a new target for potential treatments.

New therapeutic avenues for improving the synchronization of the body’s various clocks may be opening up.

The odds of children becoming overweight go up with sleep-disordered breathing and short sleep duration, underscoring the need for early identification of these risk factors.

The risk of new-onset obstructive sleep apnea appears to be greater in persons who have asthma. Treating one may help the other.

Pages

Subscribe to Sleep Disorders on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.